Astrana Health, Inc. (NASDAQ:ASTH) Shares Sold by Great Lakes Advisors LLC

Great Lakes Advisors LLC cut its stake in shares of Astrana Health, Inc. (NASDAQ:ASTH) by 20.6% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 32,101 shares of the company’s stock after selling 8,346 shares during the period. Great Lakes Advisors LLC owned about 0.06% of Astrana Health worth $1,012,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Amalgamated Bank acquired a new stake in shares of Astrana Health in the third quarter valued at about $713,000. Principal Financial Group Inc. acquired a new stake in shares of Astrana Health in the third quarter valued at about $13,383,000. Victory Capital Management Inc. acquired a new stake in shares of Astrana Health in the third quarter valued at about $2,596,000. KBC Group NV acquired a new stake in shares of Astrana Health in the third quarter valued at about $70,000. Finally, Royce & Associates LP acquired a new stake in shares of Astrana Health in the third quarter valued at about $6,661,000. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Astrana Health Trading Up 0.5 %

Shares of ASTH stock opened at $29.34 on Friday. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91. The firm has a market cap of $1.65 billion, a PE ratio of 22.57, a price-to-earnings-growth ratio of 1.37 and a beta of 1.30. The company has a 50-day moving average of $33.96 and a two-hundred day moving average of $43.10. Astrana Health, Inc. has a 1-year low of $23.12 and a 1-year high of $63.20.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings data on Thursday, February 27th. The company reported ($0.15) EPS for the quarter, missing the consensus estimate of $0.22 by ($0.37). Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The business had revenue of $665.21 million during the quarter, compared to analysts’ expectations of $617.24 million. On average, analysts predict that Astrana Health, Inc. will post 1.15 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on ASTH shares. Robert W. Baird cut their price objective on shares of Astrana Health from $86.00 to $50.00 and set an “outperform” rating for the company in a research report on Monday, March 3rd. Truist Financial cut their price objective on shares of Astrana Health from $59.00 to $50.00 and set a “buy” rating for the company in a research report on Monday, January 13th. Bank of America cut their price objective on shares of Astrana Health from $55.00 to $49.00 and set a “buy” rating for the company in a research report on Tuesday, March 4th. Stifel Nicolaus cut their price objective on shares of Astrana Health from $70.00 to $56.00 and set a “buy” rating for the company in a research report on Thursday, February 20th. Finally, Macquarie upgraded shares of Astrana Health to a “hold” rating in a research report on Monday, December 16th. Two analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $56.83.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.